 It is known that glioblastomas have mutations that are specific to an individual patients tumor. These mutations can cause the tumor cells to produce proteins that appear very different from the bodys own cells. It is possible that these proteins used in a vaccine may induce strong immune responses, which may help the body fight any tumor cells that could cause glioblastoma to recur. 